A phase I and pharmacokinetic study of BAY59: a novel taxane.
Ramnath N, Hamm J, Schwartz G, Holden S, Eckhardt SG, Vredenburg MR, Bernacki RJ, Lathia C, Kanter P, Creaven PJ.
Ramnath N, et al. Among authors: vredenburg mr.
Oncology. 2004;67(2):123-9. doi: 10.1159/000080998.
Oncology. 2004.
PMID: 15539916
Clinical Trial.